Who We Are:
Jefferson’s Prostate Cancer Program is one of only 8 NCI-Designated Prostate Cancer Centers of Excellence in the United States, and is the first in the nation to demonstrate that the multidisciplinary clinical approach improves outcomes for men with aggressive forms of prostate cancer. The multidisciplinary team is comprised of some of the leading physicians and researchers in their respective fields.
Why We Need Your Support:
Your gift to the Prostate Cancer Program will provide essential support for:
-
Our Cancer Risk Assessment and Clinical Cancer Genetics program as it works to provide prostate cancer patients and their families with genetic information on inherited cancer risk through informed screening, treatment and prevention approaches.
-
Our expansion of access to clinical trials, which allow our patients to have treatments tailored to fit their best standard of care and our researchers and doctors to broaden their understanding and treatment of prostate cancer.
-
Translational research to advance and further discoveries into new drugs, therapies and technologies.
